TRAILBLAZER-ALZ 2 – Lilly

Have you started noticing changes in your memory or ability to think clearly?

A clinical research study for those with early symptomatic Alzheimer’s disease.

If you are noticing changes in your memory or ability to think clearly, you may pre-qualify for a clinical research study for early symptomatic Alzheimer’s disease.

In order to meet study eligibility criteria the participant must:

*The study partner must be able to speak about the participant’s day to day routines and any changes with the research staff throughout the study

Other eligibility criteria will apply.

Study-related care will be provided at no cost to you.

When it comes to questions about your health, you’ve always sought out the answers. Why stop now?

Study-related care is provided at no cost to you.

Health insurance is not required.​

About Early Symptomatic Alzheimer’s Disease

Early symptomatic Alzheimer’s disease causes a slight but noticeable and measurable decline in cognitive abilities. It involves problems with memory, thinking, language, and judgment skills.

If you have early symptomatic Alzheimer’s disease, you may be noticing changes in your memory. You may feel like your mental functions are “slipping”, but the changes have not become severe enough to significantly interrupt your daily life.

Approximately
15% to  15 %
of people age 65 or older have mild cognitive impairment (MCI), an indicator of early symptomatic Alzheimer’s disease.
Someone with early symptomatic Alzheimer’s disease is at an increased risk of developing Alzheimer’s Disease or another dementia.
The risk factors most strongly linked to Alzheimer’s Disease are advancing age, family history of Alzheimer’s or another dementia, and conditions that raise risk for cardiovascular disease.

The causes and treatment of Alzheimer’s Disease are not yet understood, but clinical research studies like TRAILBLAZER-ALZ 2 are committed to finding the answers.

[Site Logo]

[Site Name]

[PI Name]

[Site Address]

Scroll to Top